Health
Novo's CagriSema obesity shot cut women's weight by 25% in 68 weeks, new analysis shows
The Wegovy successor, due to launch early next year, worked across menopause stages in a follow-up look at its late-stage trial. Here is what the numbers mean.
20 Oct 2026




